Compared with CBF AML, CEBPA, WT1, NPM1 and IDH1/2 cooccurred more frequently in KIT mut/CBF-neg AML with statistically significance (see Supplemental Fig. 2). This evidence concerns the gene CEBPZ and acute myeloid leukemia.